George B. Abercrombie, Director at BIOCRYST PHARMACEUTICALS INC (BCRX), bought 3,000 shares at $6.19 ($19K) on 2013-11-12, disclosed to the SEC on 2013-11-13.
Open-market purchase of $19k BCRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| BCRX | SELL | 2021-11-17 | $61K | — | Filing → |
| BCRX | SELL | 2021-09-17 | $75K | — | Filing → |
| BCRX | SELL | 2021-09-14 | $1.1M | — | Filing → |